Logo image of HCWC

HEALTHY CHOICE WELLNESS CORP (HCWC) Stock Fundamental Analysis

NYSEARCA:HCWC - NYSE Arca - US42227T1051 - Common Stock - Currency: USD

0.75  +0.04 (+5.63%)

Fundamental Rating

1

Taking everything into account, HCWC scores 1 out of 10 in our fundamental rating. HCWC was compared to 40 industry peers in the Consumer Staples Distribution & Retail industry. HCWC may be in some trouble as it scores bad on both profitability and health. HCWC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

HCWC had negative earnings in the past year.
HCWC Yearly Net Income VS EBIT VS OCF VS FCFHCWC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -2M -4M -6M -8M

1.2 Ratios

HCWC has a worse Return On Assets (-29.93%) than 89.74% of its industry peers.
With a Return On Equity value of -338.91%, HCWC is not doing good in the industry: 94.87% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -29.93%
ROE -338.91%
ROIC N/A
ROA(3y)-22.16%
ROA(5y)N/A
ROE(3y)-56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HCWC Yearly ROA, ROE, ROICHCWC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 -20 -40 -60 -80 -100

1.3 Margins

The Gross Margin of HCWC (36.54%) is better than 84.62% of its industry peers.
HCWC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HCWC Yearly Profit, Operating, Gross MarginsHCWC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 10 -10 20 30

More info and screens

0

2. Health

2.1 Basic Checks

HCWC does not have a ROIC to compare to the WACC, probably because it is not profitable.
HCWC has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for HCWC is higher compared to a year ago.
HCWC Yearly Shares OutstandingHCWC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M 8M
HCWC Yearly Total Debt VS Total AssetsHCWC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 10M 20M 30M

2.2 Solvency

HCWC has an Altman-Z score of 1.33. This is a bad value and indicates that HCWC is not financially healthy and even has some risk of bankruptcy.
HCWC's Altman-Z score of 1.33 is on the low side compared to the rest of the industry. HCWC is outperformed by 79.49% of its industry peers.
HCWC has a Debt/Equity ratio of 3.31. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 3.31, HCWC is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 3.31
Debt/FCF N/A
Altman-Z 1.33
ROIC/WACCN/A
WACC7.96%
HCWC Yearly LT Debt VS Equity VS FCFHCWC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 5M 10M 15M

2.3 Liquidity

HCWC has a Current Ratio of 0.87. This is a bad value and indicates that HCWC is not financially healthy enough and could expect problems in meeting its short term obligations.
HCWC has a Current ratio of 0.87. This is in the lower half of the industry: HCWC underperforms 79.49% of its industry peers.
A Quick Ratio of 0.25 indicates that HCWC may have some problems paying its short term obligations.
HCWC's Quick ratio of 0.25 is on the low side compared to the rest of the industry. HCWC is outperformed by 74.36% of its industry peers.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.25
HCWC Yearly Current Assets VS Current LiabilitesHCWC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M 8M

More info and screens

1

3. Growth

3.1 Past

HCWC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -198.93%.
Looking at the last year, HCWC shows a very strong growth in Revenue. The Revenue has grown by 91.97%.
EPS 1Y (TTM)-198.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)91.97%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HCWC Yearly Revenue VS EstimatesHCWC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 10M 20M 30M 40M 50M
HCWC Yearly EPS VS EstimatesHCWC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

HCWC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HCWC Price Earnings VS Forward Price EarningsHCWC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HCWC Per share dataHCWC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HCWC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HEALTHY CHOICE WELLNESS CORP

NYSEARCA:HCWC (2/11/2025, 12:13:31 PM)

0.75

+0.04 (+5.63%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change-3.45%
Ins Owners19.06%
Ins Owner Change1.64%
Market Cap7.37M
AnalystsN/A
Price TargetN/A
Short Float %4%
Short Ratio0.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.13
P/FCF N/A
P/OCF N/A
P/B 2.51
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS5.67
BVpS0.3
TBVpS-0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.93%
ROE -338.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.54%
FCFM N/A
ROA(3y)-22.16%
ROA(5y)N/A
ROE(3y)-56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.68
Health
Industry RankSector Rank
Debt/Equity 3.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.87
Quick Ratio 0.25
Altman-Z 1.33
F-ScoreN/A
WACC7.96%
ROIC/WACCN/A
Cap/Depr(3y)20.94%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.71%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-198.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)91.97%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-38.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-53.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.46%
OCF growth 3YN/A
OCF growth 5YN/A